Mechanistic insights into MicroRNA-induced Neuronal Reprogramming of Human Adult Fibroblasts January 30, 2024 Andrew S. Yoo
Application of predictive models in boosting power of Alzheimer’s disease clinical trials: A post hoc analysis of phase 3 solanezumab trials January 30, 2024 Ali Ezzati, Richard Lipton
Mammalian Ddi2 is a shuttling factor containing a retroviral protease domain that influences binding of ubiquitylated proteins and proteasomal degradation January 30, 2024 Alfred L. Goldberg
Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies January 30, 2024 Alfred L. Goldberg
26S proteasomes become stably activated upon heat shock when ubiquitination and protein degradation increase January 30, 2024 Alfred L. Goldberg
26S Proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation January 30, 2024 Alfred L. Goldberg
Proteins containing ubiquitin-like (Ubl) domains not only bind to 26S proteasomes but also induce their activation January 30, 2024 Alfred L. Goldberg
cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases January 30, 2024 Alfred L. Goldberg
ZFand5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation January 30, 2024 Alfred L. Goldberg